Cargando…

Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology

Cancer is a fatal disease and the second most cause of death worldwide. Treatment of cancer is a complex process and requires a multi-modality-based approach. Cancer detection and treatment starts with screening/diagnosis and continues till the patient is alive. Screening/diagnosis of the disease is...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Ashish Kumar, Mithun, Sneha, Sherkhane, Umeshkumar B., Dwivedi, Pooj, Puts, Senders, Osong, Biche, Traverso, Alberto, Purandare, Nilendu, Wee, Leonard, Rangarajan, Venkatesh, Dekker, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501896/
https://www.ncbi.nlm.nih.gov/pubmed/37720353
http://dx.doi.org/10.37349/etat.2023.00153
_version_ 1785106204944498688
author Jha, Ashish Kumar
Mithun, Sneha
Sherkhane, Umeshkumar B.
Dwivedi, Pooj
Puts, Senders
Osong, Biche
Traverso, Alberto
Purandare, Nilendu
Wee, Leonard
Rangarajan, Venkatesh
Dekker, Andre
author_facet Jha, Ashish Kumar
Mithun, Sneha
Sherkhane, Umeshkumar B.
Dwivedi, Pooj
Puts, Senders
Osong, Biche
Traverso, Alberto
Purandare, Nilendu
Wee, Leonard
Rangarajan, Venkatesh
Dekker, Andre
author_sort Jha, Ashish Kumar
collection PubMed
description Cancer is a fatal disease and the second most cause of death worldwide. Treatment of cancer is a complex process and requires a multi-modality-based approach. Cancer detection and treatment starts with screening/diagnosis and continues till the patient is alive. Screening/diagnosis of the disease is the beginning of cancer management and continued with the staging of the disease, planning and delivery of treatment, treatment monitoring, and ongoing monitoring and follow-up. Imaging plays an important role in all stages of cancer management. Conventional oncology practice considers that all patients are similar in a disease type, whereas biomarkers subgroup the patients in a disease type which leads to the development of precision oncology. The utilization of the radiomic process has facilitated the advancement of diverse imaging biomarkers that find application in precision oncology. The role of imaging biomarkers and artificial intelligence (AI) in oncology has been investigated by many researchers in the past. The existing literature is suggestive of the increasing role of imaging biomarkers and AI in oncology. However, the stability of radiomic features has also been questioned. The radiomic community has recognized that the instability of radiomic features poses a danger to the global generalization of radiomic-based prediction models. In order to establish radiomic-based imaging biomarkers in oncology, the robustness of radiomic features needs to be established on a priority basis. This is because radiomic models developed in one institution frequently perform poorly in other institutions, most likely due to radiomic feature instability. To generalize radiomic-based prediction models in oncology, a number of initiatives, including Quantitative Imaging Network (QIN), Quantitative Imaging Biomarkers Alliance (QIBA), and Image Biomarker Standardisation Initiative (IBSI), have been launched to stabilize the radiomic features.
format Online
Article
Text
id pubmed-10501896
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Open Exploration Publishing
record_format MEDLINE/PubMed
spelling pubmed-105018962023-09-16 Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology Jha, Ashish Kumar Mithun, Sneha Sherkhane, Umeshkumar B. Dwivedi, Pooj Puts, Senders Osong, Biche Traverso, Alberto Purandare, Nilendu Wee, Leonard Rangarajan, Venkatesh Dekker, Andre Explor Target Antitumor Ther Review Cancer is a fatal disease and the second most cause of death worldwide. Treatment of cancer is a complex process and requires a multi-modality-based approach. Cancer detection and treatment starts with screening/diagnosis and continues till the patient is alive. Screening/diagnosis of the disease is the beginning of cancer management and continued with the staging of the disease, planning and delivery of treatment, treatment monitoring, and ongoing monitoring and follow-up. Imaging plays an important role in all stages of cancer management. Conventional oncology practice considers that all patients are similar in a disease type, whereas biomarkers subgroup the patients in a disease type which leads to the development of precision oncology. The utilization of the radiomic process has facilitated the advancement of diverse imaging biomarkers that find application in precision oncology. The role of imaging biomarkers and artificial intelligence (AI) in oncology has been investigated by many researchers in the past. The existing literature is suggestive of the increasing role of imaging biomarkers and AI in oncology. However, the stability of radiomic features has also been questioned. The radiomic community has recognized that the instability of radiomic features poses a danger to the global generalization of radiomic-based prediction models. In order to establish radiomic-based imaging biomarkers in oncology, the robustness of radiomic features needs to be established on a priority basis. This is because radiomic models developed in one institution frequently perform poorly in other institutions, most likely due to radiomic feature instability. To generalize radiomic-based prediction models in oncology, a number of initiatives, including Quantitative Imaging Network (QIN), Quantitative Imaging Biomarkers Alliance (QIBA), and Image Biomarker Standardisation Initiative (IBSI), have been launched to stabilize the radiomic features. Open Exploration Publishing 2023 2023-08-24 /pmc/articles/PMC10501896/ /pubmed/37720353 http://dx.doi.org/10.37349/etat.2023.00153 Text en © The Author(s) 2023. https://creativecommons.org/licenses/by/4.0/This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Jha, Ashish Kumar
Mithun, Sneha
Sherkhane, Umeshkumar B.
Dwivedi, Pooj
Puts, Senders
Osong, Biche
Traverso, Alberto
Purandare, Nilendu
Wee, Leonard
Rangarajan, Venkatesh
Dekker, Andre
Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
title Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
title_full Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
title_fullStr Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
title_full_unstemmed Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
title_short Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
title_sort emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501896/
https://www.ncbi.nlm.nih.gov/pubmed/37720353
http://dx.doi.org/10.37349/etat.2023.00153
work_keys_str_mv AT jhaashishkumar emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT mithunsneha emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT sherkhaneumeshkumarb emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT dwivedipooj emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT putssenders emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT osongbiche emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT traversoalberto emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT purandarenilendu emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT weeleonard emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT rangarajanvenkatesh emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology
AT dekkerandre emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology